Barriers to participation and lifestyle change among lower versus higher income participants in the National Diabetes Prevention Program: lifestyle coach perspectivesKatherine J. W. Baucom, Megha Shah, Natalie D. Ritchie et al.|Translational Behavioral Medicine|2022Cited by 28
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) StudyCassidy A. Gutner, Maggie Czarnogorski, Marc van der Valk et al.|Journal of the International Association of Providers of AIDS Care (JIAPAC)|2024Cited by 14
Promises and Pitfalls of Dyads in the National Diabetes Prevention Program: Lifestyle Coach PerspectivesKatherine J. W. Baucom, Lauren Clark, Tali Bauman et al.|American Journal of Health Promotion|2022Cited by 7
Adapting the National Diabetes Prevention Program: Learning from Lifestyle Coach strategies and adjustments during the COVID-19 pandemic in the United StatesMadelyn Whitaker, Katherine J. W. Baucom, Megha Shah et al.|Preventive Medicine Reports|2024Cited by 0